Pony's death shines a light on drug use in equestrian sports

12/30/2012 | New York Times (tiered subscription model), The

Use of performance-enhancing drugs has been debated in horse racing circles for some time, and now the topic is being discussed in the equestrian world after the May 26 competition death of a pony cast a spotlight on the issue. This report identifies several weaknesses in oversight of drug use in equestrian animals, including the fact that while only veterinarians can administer drugs intravenously to racehorses, anyone can do so at horse shows, which are largely volunteer-run. However, the United States Equestrian Federation says it has worked to be proactive on the issue and has assembled a task force to investigate and find ways to tighten oversight.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC